Vijay Pande, a founding general partner at a16z Bio + Health, and Julie Yoo, a fellow general partner at the same firm, explore the transformative challenges of integrating AI into healthcare. They discuss the potential of AI to streamline workflows, enhance doctor-patient interactions, and revolutionize clinical trials. The conversation touches on using AI for patient triage in emergency care and the shift towards value-based care, emphasizing the need for specialized AI models to interpret complex medical data while overcoming systemic barriers.

Vijay Pande and Julie Yoo from a16z Bio + Health discuss grand challenges in healthcare AI, including AI integration in healthcare workflows, value-based care, and innovation in clinical trials. They also share their thoughts on the AI startups they hope to see in the industry.

At the end of 2022, our team at a16z asked dozens of partners across the firm to spotlight one big idea that startups in their fields could tackle in 2023.Emerging from this exercise came 40+ builder-worthy pursuits for the year, ranging from entertainment franchise games to precision delivery of medicine to small modular reactors, and of course loads of AI applications.In our 2-part series, we’ll be covering 12 of these big ideas with the partners that shared them.Here in part 2, we’ll cover Fintech, American Dynamism, and Bio & Health. Listen in as we chat with Anish Acharya, Angela Strange, Michelle Volz, Ryan McEntush, Vijay Pande, and Julie Yoo.And for the full list of 40+ ideas, check out the full article: https://a16z.com/2022/12/15/big-ideas-in-tech-2023/Topics Covered:(0:59) GPT Unlocks Credit Counseling - Anish Acharya(9:53) Compliance as a Competitive Advantage - Angela Strange(23:31) Small Modular Reactors Advance the Nuclear Renaissance - Michelle Volz(33:48) Overhauling the Space Supply Chain - Ryan McEntush(44:40) The Biggest Company in the World - Vijay Pande(51:17) The Value-Based Care Stack - Julie YooResources:https://a16z.com/2022/11/02/america-space-age/https://a16z.com/2022/11/11/the-biggest-company-in-the-world/https://a16z.com/2021/01/08/the-new-tech-stack-for-virtual-first-care/ Stay Updated: Find us on Twitter: https://twitter.com/a16zFind us on LinkedIn: https://www.linkedin.com/company/a16zSubscribe on your favorite podcast app: https://a16z.simplecast.com/Follow our host: https://twitter.com/stephsmithioPlease note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. For more details please see a16z.com/disclosures.

Guests Julie Yoo and Jay Rughani from a16z Bio + Health discuss AI adoption in healthcare with executives, covering topics like improving efficiency, patient messaging, measuring tech ROI, navigating adoption challenges, and building strategic partnerships.

Jorge Conde and Julie Yoo discuss the unique challenges of building a software company in healthcare, including regulations, market dynamics, and barriers to entry. They also explore the importance of balancing software and human services, data analysis, timing, achieving product-market fit, and navigating regulatory issues and incumbents in the industry.

Primary care was meant to be the front door to the healthcare system, but in some ways never set up for success to begin with. We need a new operating system for primary care—one with a different, deeper understanding of the patient, the context of their world around them, and the processes we have in place to figure out who sees a doctor and when, to use the system most efficiently.In this episode of the a16z Podcast, we talk about what the primary care of the future should actually look like; what kind of data about patients we should be collecting, from where, and to tell us what; how you ask the right questions of that data, to use the resources of our  healthcare system most efficiently and for the best care; and what the PCP of the future might look like. Joining us for the conversation are General Partner Julie Yoo, physician entrepreneur Ivor Horn, a primary care pediatrician for more than 20 years, and Jeff Kaditz, CEO and founder of Q.bio, a platform that identifies and monitors each individual’s biggest health risks. 

Vijay Pande and Julie Yoo, general partners at a16z with a focus on healthcare technology and AI, tackle the intriguing fusion of AI and healthcare. They discuss how AI can dramatically reduce healthcare costs while improving patient experiences. The conversation dives into the complexities of regulatory challenges and the critical need for innovative data generation over traditional methods. They explore personalized healthcare through advancements in precision medicine, highlighting how understanding patient phenotypes can revolutionize care.

Julie Yoo, General Partner at Andreessen Horowitz, discusses opportunities in digital healthcare, their approach to healthcare investing, and her journey from operator to investor. Topics include the market for patient data, the value of robust patient data, unbundling hospital systems, and the mindset shift from operator to investor.

with @JorgeCondeBio, @julesyoo, and @omnivorousreadIn some ways, the coronavirus feels like it came out of nowhere—a kind of Black Swan event. But at the same time, it's been exposing a lot of the fundamental flaws in our healthcare system that now feel like a perfect storm coming together... and have hurt our ability to address the problem that we should really have seen coming.In this episode, a16z General Partners Jorge Conde and Julie Yoo talk with Hanne Tidnam about some of those big forces and dynamics in the healthcare system, at the intersection of business, policy, and public health: how in healthcare like perhaps nowhere else, broken policy can lead to broken business models that, in the wrong circumstances, can then lead major failures in public health like the one we’re seeing today; where we’ve seen this before, in the markets of vaccines, antibiotics, and diagnostics; and what should be different next time, so that when a new pandemic hits we aren’t facing another perfect storm.

We’re at a moment where we are now seeing medicine go virtual faster, and at a scale that it has never done before. In this conversation,  a16z bio general partners Vijay Pande and Julie Yoo, who come from the worlds of bio, technology and care delivery,  talk with Hanne Tidnam all about what exactly virtual care and “telemedicine” is... and what it isn’t; what it works well for, what doesn’t (yet), and where there’s potential; and finally, the current pain points (including regulation), and what we’ll learn from this current moment for the next generation of virtual medicine tools.